Information Journal Paper
APA:
Copy. (2020). What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2?. Dermatologic Therapy, 33(6), 0-0. SID. https://sid.ir/paper/781755/en
Vancouver:
Copy. What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2?. Dermatologic Therapy[Internet]. 2020;33(6):0-0. Available from: https://sid.ir/paper/781755/en
IEEE:
Copy, “What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2?,” Dermatologic Therapy, vol. 33, no. 6, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/781755/en